ClinicalTrials.Veeva

Menu

Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Orthopedic Surgery

Treatments

Drug: palonosetron
Drug: palonosetron with dexamethasone

Study type

Interventional

Funder types

Other

Identifiers

NCT02744508
4-2015-0232

Details and patient eligibility

About

Postoperative nausea and vomiting (PONV) is related with extended hospital day and risk factor of aspiration pneumonia. Postoperative patient controlled intravenous analgesia is related with postoperative nausea and vomiting. Selective 5-HT3 antagonist, Palonosetron, is the most recent medication for prevention of PONV. Purpose of our study is comparison of PONV preventive effect of palonosetron and combination of palonosetron and dexamethasone.

Enrollment

202 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who are undergoing minor orthopedic surgery.
  • IV patient controlled analgesia

Exclusion criteria

    1. minority (0~19 year)
  • patients who are belongs to ASA class 3 or more, and have underlying complicated cardiovascular or psychological disease.
  • Steroid medication
  • Diabetes Mellitus medication

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

202 participants in 2 patient groups

P group
Active Comparator group
Description:
Palonosetron group
Treatment:
Drug: palonosetron
PD group
Experimental group
Description:
Palonosetron and dexamethasone group
Treatment:
Drug: palonosetron with dexamethasone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems